What is the Daito Pharmaceutical Co., Ltd. stock price forecast?

Daito Pharmaceutical Co., Ltd. is currently trading at ¥1,207. View real-time AI analysis on Alpha Lenz.

What is Daito Pharmaceutical Co., Ltd. insider trading activity?

View the latest insider trading data for Daito Pharmaceutical Co., Ltd. on Alpha Lenz.

What is Daito Pharmaceutical Co., Ltd.'s P/E ratio?

Daito Pharmaceutical Co., Ltd.'s P/E ratio is 19.0.

Daito Pharmaceutical Co., Ltd.

JPX · 4577

¥1,207-2(-0.17%)Market closed

Ask about Daito Pharmaceutical Co., Ltd.'s future dividend policy...

Alpha Chat Insight

“Daito Pharmaceutical Co., Ltd. trades at a P/E of 19.0 (fair value) with modest ROE of 3.7%.”

Ask for details →

Company Overview

Daito Pharmaceutical Co., Ltd. is a prominent pharmaceutical company specializing in the research, development, and production of pharmaceutical products. It primarily operates within the healthcare sector, providing a range of drugs that serve various therapeutic needs. The company's product portfolio includes prescription medications, over-the-counter drugs, and generic formulations meeting diverse medical requirements. Daito Pharmaceutical Co., Ltd. also engages in the production of active pharmaceutical ingredients, which are fundamental components in drug formulation. With a focus on innovation, the company is involved in extensive R&D activities aimed at discovering new medicines and improving existing formulations. Its significant role in the pharmaceutical industry underscores its contribution to advancing healthcare solutions, supporting medical treatment, and enhancing patient health outcomes globally.

CEOHiroshi Matsumori

Websitehttps://www.daitonet.co.jp

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Employees1,073

Company Statistics

FY 2025

Profile

¥36,193,229,942Market Cap

¥50,643,000,000Revenue

0.00Shares Out

1,073Employees

Margins

17.05%Gross

14.13%EBITDA

5.17%Operating

5.84%Pre-Tax

3.49%Net

Valuation

18.97P/E

0.70P/B

0.71EV/Sales

6.42EV/EBITDA

-31.94P/FCF

Growth (CAGR)

5.23%Rev 3Yr

2.39%Rev 5Yr

-26.33%Op Inc 3Yr

-13.33%Op Inc 5Yr

-27.48%Net Inc 3Yr

-14.77%Net Inc 5Yr

Returns

2.27%ROA

3.67%ROE

3.96%ROIC

Financial Health

¥2,207,000,000Cash & Cash Equivalents

¥23,730,000,000Net Debt

49.81%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Daito Pharmaceutical Co., Ltd. trades at a P/E of 19.0 (fair value) with modest ROE of 3.7%.”

Ask for details →

Frequently Asked Questions

Daito Pharmaceutical Co., Ltd. (ticker: 4577) is a company listed on JPX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 1,073 employees. Market cap is $36.2B.

The current price is 1,207 with a P/E ratio of 18.97x and P/B of 0.7x.

ROE is 3.67% and operating margin is 5.17%. Annual revenue is $50.6B.